Project information
Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies
- Project Identification
- MSM0021622430
- Project Period
- 1/2007 - 12/2013
- Investor / Pogramme / Project type
-
Ministry of Education, Youth and Sports of the CR
- Research Intents
- MU Faculty or unit
- Faculty of Medicine
- Other MU Faculty/Unit
- Faculty of Science
- Other MU Faculty/Unit
- Faculty of Informatics
- Other MU Faculty/Unit
- Central European Institute of Technology
- Keywords
- embryonic stem cells
The goal of this project will be a) to profit from availability of unique cellular resources - mouse and human embryonic stem cells and normal and malignant hematopoietic stem/progenitor cells, b) to effectively employ a wide variety of current and complementary methodologies available to the consortium, and c) to exploit a proven/certified expertise in working with various living systems that span from in vitro cultured cells, through animal models to oncohematological patients. All this together will represent a powerful experimental platform aimed at addressing a nature of molecules and molecular mechanisms underlaying phenomena that are common to both normal and cancer stem cells, mainly their ability to self-renew and to enter differentiation pathways. Integral part of this general goal is to implement multifaceted analytical approach that will cover studies of gene expression at both mRNA and protein levels, evaluating function of extra and intracellular signaling pathways, and analyzing biological properties of cells in vitro and in vivo. Expected outcome will be not only understanding but also a definition of molecules and/or molecular pathways to be tested as therapeutic targets, and cellular models that will make such testing feasible.
Publications
Total number of publications: 356
2012
-
p38 Inhibition ameliorates skin and skull abnormalities in Fgfr2 Beare-Stevenson mice.
The journal of clinical investigation, year: 2012, volume: 122, edition: 6, DOI
-
Phosphoinositide 3-kinase inhibition enables retinoic acid-induced neurogenesis in monolayer culture of embryonic stem cells.
J Cell Biochem, year: 2012, volume: 113, edition: 2, DOI
-
Receptor tyrosine kinases activate canonical WNT/beta catenin signaling via MAP kinase/LRP6 pathway and direct beta-Catenin phosphorylation
Plos One, year: 2012, volume: 7, edition: 4, DOI
-
Relative expression of gammadelta T-cell receptor gene families detected by RT–PCR and capillary electrophoresis
International Journal of immunogenetics, year: 2012, volume: 39, edition: 5, DOI
-
Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia
Leukemia Research, year: 2012, volume: 36, edition: 10, DOI
-
Role of treatment in the appearance and selection of BCR-ABL1 kinase domain mutations
Molecular diagnosis and therapy, year: 2012, volume: 16, edition: 4
-
SEM and ESEM Observation of Stem Cells. Comparative Study of Human Embryonic Stem Cell Morphology.
Imaging & Microscopy, year: 2012, volume: 2012, edition: 4
-
Sequence variations in miRNA genes are common and may affect their expression in patients with chronic lymphocytic leukemia
Year: 2012, type: Conference abstract
-
SFRP1 and SFRP2 dose-dependently regulate midbrain dopamine neuron development in vivo and in embryonic stem cells.
Stem Cells, year: 2012, volume: 30, edition: 5, DOI
-
Sixteen years and counting: the current understanding of fibroblast growth factorreceptor 3 (FGFR3) signaling in skeletal dysplasias.
Human Mutation, year: 2012, volume: 33, edition: 1, DOI